Ellen G. McMahon

2.7k total citations
45 papers, 2.1k citations indexed

About

Ellen G. McMahon is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ellen G. McMahon has authored 45 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 18 papers in Cardiology and Cardiovascular Medicine and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ellen G. McMahon's work include Receptor Mechanisms and Signaling (11 papers), Hormonal Regulation and Hypertension (10 papers) and Renin-Angiotensin System Studies (10 papers). Ellen G. McMahon is often cited by papers focused on Receptor Mechanisms and Signaling (11 papers), Hormonal Regulation and Hypertension (10 papers) and Renin-Angiotensin System Studies (10 papers). Ellen G. McMahon collaborates with scholars based in United States, France and Australia. Ellen G. McMahon's co-authors include Amy E. Rudolph, Eric A.G. Blomme, Ricardo Rocha, Maria A. Palomo, Eileen Blasi, Susan M. Garthwaite, William M. Moore, Gillian M. Olins, Michael Stern and John F. McDonald and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Ellen G. McMahon

44 papers receiving 2.1k citations

Peers

Ellen G. McMahon
Kiyotaka Kugiyama Japan
Terrance D. Barrett United States
N. C. Trippodo United States
Kazuoki Kondo Japan
Mara Ferrandi Italy
David R. Powell United States
Anselm T. Bäumer Germany
Gert M. Kostner Austria
Kenichi Yasunari Japan
Reyadh Redha United States
Kiyotaka Kugiyama Japan
Ellen G. McMahon
Citations per year, relative to Ellen G. McMahon Ellen G. McMahon (= 1×) peers Kiyotaka Kugiyama

Countries citing papers authored by Ellen G. McMahon

Since Specialization
Citations

This map shows the geographic impact of Ellen G. McMahon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen G. McMahon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen G. McMahon more than expected).

Fields of papers citing papers by Ellen G. McMahon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen G. McMahon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen G. McMahon. The network helps show where Ellen G. McMahon may publish in the future.

Co-authorship network of co-authors of Ellen G. McMahon

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen G. McMahon. A scholar is included among the top collaborators of Ellen G. McMahon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen G. McMahon. Ellen G. McMahon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garthwaite, Susan M. & Ellen G. McMahon. (2004). The evolution of aldosterone antagonists. Molecular and Cellular Endocrinology. 217(1-2). 27–31. 130 indexed citations
2.
Qin, Wenning, Amy E. Rudolph, Brian R. Bond, et al.. (2003). Transgenic Model of Aldosterone-Driven Cardiac Hypertrophy and Heart Failure. Circulation Research. 93(1). 69–76. 197 indexed citations
3.
Blasi, Eileen, et al.. (2003). Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney International. 63(5). 1791–1800. 431 indexed citations
4.
McMahon, Ellen G.. (2003). Eplerenone, a New Selective Aldosterone Blocker. Current Pharmaceutical Design. 9(13). 1065–1075. 6 indexed citations
5.
Ross, Stuart A., Xiaoli Chen, Heidi R. Hope, et al.. (2000). Development and Comparison of Two 3T3-L1 Adipocyte Models of Insulin Resistance: Increased Glucose Flux vs Glucosamine Treatment. Biochemical and Biophysical Research Communications. 273(3). 1033–1041. 50 indexed citations
6.
Olins, Gillian M., et al.. (1995). Elucidation of the insurmountable nature of an angiotensin receptor antagonist, SC-54629.. Molecular Pharmacology. 47(1). 115–120. 17 indexed citations
7.
Bertenshaw, Stephen R., Roland S. Rogers, Michael Stern, et al.. (1993). Phosphorus-containing inhibitors of endothelin converting enzyme: effects of the electronic nature of phosphorus on inhibitor potency. Journal of Medicinal Chemistry. 36(1). 173–176. 26 indexed citations
8.
Reitz, David B., Gillian M. Olins, Ellen G. McMahon, et al.. (1993). Synthesis and structure-activity relationships of nonpeptide, potent triazolone-based angiotensin II receptor antagonists. Journal of Medicinal Chemistry. 36(15). 2172–2181. 20 indexed citations
9.
McMahon, Ellen G., et al.. (1993). Effect of Phosphoramidon (Endothelin Converting Enzyme Inhibitor) and BQ-123 (Endothelin Receptor Subtype A Antagonist) on Blood Pressure in Hypertensive Rats. American Journal of Hypertension. 6(8). 667–673. 37 indexed citations
10.
Cantley, Lewis C., Katherine Spokes, Barbara A. Clark, et al.. (1993). Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction. Kidney International. 44(6). 1217–1223. 112 indexed citations
11.
Bovy, Philippe R., David B. Reitz, Joseph T. Collins, et al.. (1993). Nonpeptide angiotensin II antagonists: N-phenyl-1H-pyrrole derivatives are angiotensin II receptor antagonists. Journal of Medicinal Chemistry. 36(1). 101–110. 34 indexed citations
12.
Cosentino, Francesco, et al.. (1993). Effect of EndothelinA-Receptor Antagonist BQ-123 and Phosphoramidon on Cerebral Vasospasm. Journal of Cardiovascular Pharmacology. 22(Supplement 8). S332–S335. 48 indexed citations
13.
Olins, Gillian M., Ellen G. McMahon, Maria A. Palomo, et al.. (1992). In vitro pharmacology of a nonpeptidic angiotensin II receptor antagonist, SC-51316.. Journal of Pharmacology and Experimental Therapeutics. 261(3). 1037–1043. 21 indexed citations
14.
Bovy, Philippe R., Joseph T. Collins, Gillian M. Olins, Ellen G. McMahon, & William Hutton. (1991). Conformationally restricted polysubstituted biphenyl derivatives with angiotensin II receptors antagonist properties. Journal of Medicinal Chemistry. 34(8). 2410–2414. 23 indexed citations
15.
Bovy, Philippe R., Gillian M. Olins, Ellen G. McMahon, et al.. (1990). Structure-activity relationships for the carboxy-terminus-truncated analogs of angiotensin II, a new class of angiotensin II antagonists. Journal of Medicinal Chemistry. 33(5). 1477–1482. 11 indexed citations
16.
Spear, Kerry L., Michael S. Brown, Emily J. Reinhard, et al.. (1990). Conformational restriction of angiotensin II: cyclic analogs having high potency. Journal of Medicinal Chemistry. 33(7). 1935–1940. 56 indexed citations
17.
Bovy, Philippe R., et al.. (1989). A carboxy-terminus truncated analog of angiotensin II, [Sar1]angiotensin II-(1-7)-amide, provides an entry to a new class of angiotensin II antagonists. Journal of Medicinal Chemistry. 32(3). 520–522. 14 indexed citations
18.
McMahon, Ellen G., et al.. (1989). In vitro and in vivo activity of chymotrypsin-activated big endothelin (porcine 1–40). Biochemical and Biophysical Research Communications. 161(2). 406–413. 28 indexed citations
19.
Gierse, James K., Peter O. Olins, Catherine S. Devine, et al.. (1989). Expression, purification, and in vivo activity of atrial natriuretic factor prohormone produced in Escherichia coli. Archives of Biochemistry and Biophysics. 271(2). 441–446. 2 indexed citations
20.
McMahon, Ellen G. & Allan Jones. (1988). Altered chloride transport in arteries from aldosterone salt-hypertensive rats. Journal of Hypertension. 6(7). 593–599. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kiyotaka Kugiyama Breakdown of academic impact, for papers by Terrance D. Barrett Breakdown of academic impact, for papers by N. C. Trippodo Breakdown of academic impact, for papers by Kazuoki Kondo Breakdown of academic impact, for papers by Mara Ferrandi Breakdown of academic impact, for papers by David R. Powell Breakdown of academic impact, for papers by Anselm T. Bäumer Breakdown of academic impact, for papers by Gert M. Kostner Breakdown of academic impact, for papers by Kenichi Yasunari Breakdown of academic impact, for papers by Reyadh Redha
Rankless by CCL
2026